AtriCure, Inc. — Director's Dealing 2021

Aug 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2021-08-06

Reporting Person: Wirick Angela L (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-06	Common Stock	S	5939	$80.21	Disposed	77941	Direct
2021-08-06	Common Stock	F	5191	$83.75	Disposed	72750	Direct

Footnotes

F1: These shares were sold pursuant to a 10b5-1 trading plan.

F2: This transaction was executed in multiple trades at prices ranging from $78.52 to $81.50 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award.